Has Robert Otte, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,168 in general payments to Robert Otte, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Otte, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Otte, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Otte, MD

Allergy & Immunology · Pittsburgh, PANPI 1386689305

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.6% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AstraZeneca at 28.0% of the total. Reporting peaked in 2022 at $365 and has fallen 65.8% since, to $125 in 2025. That places this record below the midpoint for allergy & immunology clinicians in PA, where the typical reported total is $2,436.

$1,168in general payments, 2019–2025

Across 20 payments — averaging $58.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$327
Genentech USA, Inc.$131
AbbVie$129
Grifols USA, LLC$125
Blueprint Medicines Corporation$124
Pharming Healthcare, Inc.$103
plus $228 from 5 others

What the payments were for

Food & beverage$1,11696%
Education$514%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	5	$327
Genentech USA, Inc.	1	$131
AbbVie	2	$129
Grifols USA, LLC	1	$125
Blueprint Medicines Corporation	1	$124
Pharming Healthcare, Inc.	1	$103
Sanofi	1	$100
Novo Nordisk	4	$58
CSL Behring	2	$29
Regeneron Healthcare Solutions, Inc.	1	$27
Takeda Pharmaceuticals U.S.A., Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TEZSPIRE$228
Xembify$125
AYVAKIT$124
Rinvoq$106
RUCONEST$103

How this compares

$1,168 in reported general payments places this provider in the 35th percentile of 175 allergy & immunology providers in Pennsylvania.

See all allergy & immunology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$71,627

Medicare patients

171

Services billed

4,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent PenDupilumab	16	$107,173
GammaplexImmun Glob G/Sorb/Gly/Iga 0-50	17	$70,974
Dupixent SyringeDupilumab	16	$61,923
NucalaMepolizumab	16	$58,608
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	64	$47,997
Advair HfaFluticasone Propion/Salmeterol	51	$20,945
Breo ElliptaFluticasone/Vilanterol	28	$15,802
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	80	$15,154
Fluticasone Propionate HfaFluticasone Propionate	24	$5,802
Arnuity ElliptaFluticasone Furoate	18	$5,288
Azelastine Hcl	171	$4,245
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate	24	$4,183
Wixela InhubFluticasone Propion/Salmeterol	22	$3,430
Montelukast Sodium	315	$3,316
Asmanex HfaMometasone Furoate	17	$2,564

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Pittsburgh

Sergei BelenkyPittsburgh$775K
Christine RauscherPittsburgh$52K
Hey ChongPittsburgh$10K
Merritt FajtPittsburgh$10K
Drew WeissmanPhiladelphia$12.8M
Eric SchenkelBethlehem$845K
Timothy CraigHershey$564K
Sandra GawchikUpland$390K
Anthony RooklinGlen Mills$319K
Corinna BowserNarberth$229K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →